Key Points
- CEO Robert Joseph Ball bought 3,300 shares on Dec. 11 and 3,900 shares on Dec. 12 — 7,200 shares total for about $107,010 — increasing his stake (he held 114,557 shares after the Dec. 11 trade).
- Shoulder Innovations reported a quarterly EPS of ($0.48), missing the consensus of ($0.37) by $0.11 while beating revenue estimates with $11.76 million versus $9.99 million expected.
- Analysts have a consensus rating of “Moderate Buy” with an average price target of $20.60; the stock trades in a 52‑week range of $10.92–$17.94 and opened at $14.49 (50-day MA $13.45).
Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) CFO Jeffrey Points acquired 995 shares of the business's stock in a transaction on Thursday, December 11th. The stock was acquired at an average price of $14.65 per share, for a total transaction of $14,576.75. Following the acquisition, the chief financial officer owned 53,440 shares of the company's stock, valued at approximately $782,896. This trade represents a 1.90% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Shoulder Innovations Stock Up 0.8%
SI stock opened at $14.49 on Tuesday. The firm's 50 day simple moving average is $13.45. Shoulder Innovations, Inc. has a 52-week low of $10.92 and a 52-week high of $17.94.
Shoulder Innovations (NYSE:SI - Get Free Report) last posted its quarterly earnings data on Tuesday, November 11th. The company reported ($0.48) earnings per share for the quarter, missing analysts' consensus estimates of ($0.37) by ($0.11). The company had revenue of $11.76 million during the quarter, compared to the consensus estimate of $9.99 million. Sell-side analysts predict that Shoulder Innovations, Inc. will post -0.56 EPS for the current year.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on SI shares. Weiss Ratings reaffirmed a "sell (e)" rating on shares of Shoulder Innovations in a research report on Monday, December 8th. Wall Street Zen raised shares of Shoulder Innovations from a "sell" rating to a "hold" rating in a report on Saturday, October 11th. Piper Sandler reiterated an "overweight" rating and issued a $18.00 target price on shares of Shoulder Innovations in a research note on Wednesday, November 12th. BTIG Research reissued a "buy" rating and set a $23.00 price target on shares of Shoulder Innovations in a research report on Tuesday, September 9th. Finally, Morgan Stanley upped their price objective on Shoulder Innovations from $18.00 to $23.00 and gave the company an "overweight" rating in a research report on Tuesday, December 2nd. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $20.60.
Read Our Latest Stock Report on SI
Institutional Trading of Shoulder Innovations
A number of institutional investors have recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Shoulder Innovations in the third quarter worth approximately $28,000. Rhumbline Advisers purchased a new stake in Shoulder Innovations in the third quarter worth approximately $54,000. Board of Trustees of The Leland Stanford Junior University bought a new stake in Shoulder Innovations in the 3rd quarter worth approximately $170,000. Bank of America Corp DE purchased a new stake in Shoulder Innovations during the 3rd quarter valued at $322,000. Finally, Monashee Investment Management LLC bought a new position in shares of Shoulder Innovations during the 3rd quarter valued at $502,000.
Shoulder Innovations Company Profile
(
Get Free Report)
We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
